2023 ISPE Europe Annual Conference

Please Note:

  • All full-access registration (virtual & in-person) includes access to speaker presentations, on-demand content, and other conference material.
  • NOTE: Material is only available from those speakers/companies that permitted distribution.
  • Registrants will receive email notification when the on-demand content is available.
  • On-demand content is accessible for 90 days.

Access Conference Platform

Thank you to all that made 2023 ISPE Europe Annual Conference such a big success!

Thank you to our keynote speakers who kicked off the 2023 ISPE Europe Annual Conference with compelling and insightful presentations:


The pharmaceutical industry has gone through radical changes in the last years across the globe. In Europe, the pandemic has underlined the importance of a unified Europe and a strong, innovative ecosystem to address the major health challenges. With advancements in technology and policy initiatives, the pharmaceutical manufacturing landscape is further transforming.

This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry - from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies. We welcome you to participate at the 2023 ISPE Europe Annual Conference to learn and share progress, success stories, best practices, and lessons learned.

Executive Forum

The Executive Forum will address the main current issues in the pharmaceutical industry. Subject areas presented will include what the future after Covid-19 looks like, including research into new drugs based on mRNA technology and how supply chain resilience can be established in a sustainable way.

Shortages - through all stages of the value chain - materials, drugs, medical devices, and instruments is a hot topics that will be deliberated. During the forum, dialogues will focus on how digital transformation can help address these enormous problems. Additionally, the discussion will focus on what is behind the magical promise of artificial intelligence and why the value of data is currently so underestimated. We will delve into why data is considered the new gold.

You will hear from data scientists, big consultancy companies, and manufacturers on these important matters during our Executive forum sessions.

Conference Highlights

Featured Sessions

Monday, 8 May 2023
Tuesday, 9 May 2023
Wednesday, 10 May 2023


  • Recognise ways of working that relates to how the industry works to meet current and proposed regulatory requirements
  • Learn through case studies how modern engineering and project delivery drive project managers and engineers to adapt their practices to ensure consistent continuity and successful projects
  • Follow case studies on innovation in factories of the future, continuous manufacturing concepts, and production
  • Gain insight into a new world of pharmaceutical manufacturing
  • Learn how to apply a holistic view of manufacturing strategies of the future
  • Understand the operating model applied with Pharma 4.0
  • Learn about readiness qualifiers for the industry
  • Have dialogues with peer groups and with senior industry leaders on these hot topics

Cutting Edge Topics Across 5 Tracks

Given the impact of the evolving pandemic, an aging population, the increase in diseases with unmet needs, and an unprecedented rise in chronic diseases, the need for a constant focus on collaborative innovation and agility will shape Pharma’s priorities in the foreseeable future. ISPE will be the leader to set the pace for knowledge sharing that speaks to the current and future needs of the industry. 

  • Digital Transformation and Pharma 4.0

    The Digital Transformation Journey is one of the most important strategic challenges in today’s pharma organisations. The maturity of the Business Processes and the Pharmaceutical Quality System are prerequisites for moving into digital operations. Digital transformation is a holistic approach to move from paper to electronic workflow-based end-to-end operations along the value chain. This track will address the key challenges of the transformation which are: integration, cultural change, data availability, and strategic ownership based on practical case studies.

  • Manufacturing Trends – Annex 1, Digitalised Aseptic Production, Automated Production, Product Transfers to CMOs

    Applying harmonised approaches to innovative design solutions and project delivery strategies to ensure that quality therapeutic products are brought to market in an efficient manner to improve patient health will be the focus of this content area. Digitalised Aseptic—case studies and presentations with focus on the digital applications of aseptic requirements such as contamination control strategies and aseptic GMP requirements will be presented in this track. Fully Contained—closed systems case studies and technologies and their use in pharmaceutical manufacturing, and the role of Contract Manufacturing in repatriation of API and medicines production to Europe will be discussed and presented during the conference.

  • Good Engineering Practice

    Good Engineering Practice (GEP) is a combination of standards, specifications, codes, regulatory and industrial guidelines as well as accepted engineering and design methods intended to design, construct, operate, and maintain pharmaceutical and/or biotechnology facilities that encompass regulatory compliance, safety, economics, environmental protection, and operability. This track will be inspecting the transformation of engineering and project delivery in a digitalised world through best practice cases, technical presentations, and a panel discussion on information modeling.

  • Supply Chain Resiliency

    During the conference, this track will focus on the impact and potential utilisation of new technologies, processes, and disruptions on operations and logistics of the production of all types of therapies. We will be presenting content that addresses supply chain shortages; the conditions that would encourage pharmaceutical manufacturing in Europe, and the requirements for capabilities and skillsets needed for the workforce of the future.

  • GAMP 5®

    Join our speakers and validation experts for one of the most discussed topics of the year, ISPE GAMP 5® 2nd Edition. The new edition provides a substantial amount of new and updated content that the authors of the ISPE GAMP® 5 2nd Edition themselves will present. The track will provide you with in-depth insights into Computer Software Assurance, Data Integrity, Artificial Intelligence, Agile Software Development, and much more. During interactive conversations, you will have the opportunity to network and engage in discussions with the GAMP 5® community on the latest trends.

Conference Highlights

Program Committee

Head of Operations
CAM Bioceramics
Ylva EK
Robur Life Science Advisory AB
Board Liaison
Christopher J. Reid
Integrity Solutions Limited
Foundation Board Liaison
Michael A.M. ATZOR, PhD
Managing Director
Richard DENK
Senior Consultant Aseptic Processing & Containment
Jean Francois DULIERE
Reg Advisor
Technology Manager Biotechnology
CRB Group GmbH
Placeholder Person Graphic
Michael Hell, PhD
EHS Lead Global Biotech Manufacturing
Merck KGaA
Sr. Exec. Consultant
Cristina Mazo
QP - Site Manager
GP Pharma
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
Heike Roeder
Vice President QA International
Dany Shami
Head of Quality Control Raw Materials
Bayer AG
Natalia Nikolaevna Vtyurina, PhD
QA, Manager of Operations
Bristol Myers Squibb
VP Engineering
Hikma Pharmaceuticals
Heather D. WATSON
TenTenTen Consulting Ltd
Christian Woelbeling
Executive Industry Advisor
Körber Pharma Software GmbH
Thomas ZIMMER, PhD
VP European Operations

Media Partners

Pharmaceutical Online

Event Sponsors

AquaChem Nijhuis
Lachman Consultants